Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement
Sponsor: Rutgers, The State University of New Jersey
Summary
The goal of this clinical trial is to learn if intraosseous antibiotic (cefazolin) administration can improve antibiotic levels in adults undergoing primary total hip replacement. The main question it aims to answer is: • Does intraosseous cefazolin increase antibiotic concentrations in blood and tissue compared with standard intravenous cefazolin alone? Researchers will compare patients receiving intraosseous cefazolin plus standard intravenous cefazolin to those receiving placebo injection plus standard intravenous cefazolin to see if local antibiotic delivery improves outcomes. Participants will: * Receive standard intravenous cefazolin before surgery and either intraosseous cefazolin or placebo * Provide blood samples before and after antibiotic administration * Have small tissue samples collected during surgery * Complete routine postoperative follow-up and outcome assessment for 90 days
Official title: Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement: A Prospective Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2025-10-20
Completion Date
2026-11
Last Updated
2026-04-29
Healthy Volunteers
No
Conditions
Interventions
CeFAZolin 1000 MG
1 gram of ancef will be administered intra-osseously into the patient's operative side greater trochanter
Saline (0.9%, sterile, for infusion)
normal saline
Locations (1)
Robert Wood Johnson University Hospital Somerset
Somerset, New Jersey, United States